Allopregnanolone levels and symptom improvement in severe premenstrual syndrome.
about
The role of sex steroids in catamenial epilepsy and premenstrual dysphoric disorder: implications for diagnosis and treatmentNeurosteroids' effects and mechanisms for social, cognitive, emotional, and physical functionsNeurosteroids in the context of stress: implications for depressive disordersAllopregnanolone as a mediator of affective switching in reproductive mood disordersThe influence of stress at puberty on mood and learning: role of the α4βδ GABAA receptorNeurosteroid regulation of GABA(A) receptors: Focus on the alpha4 and delta subunits.Neurosteroids and GABAergic signaling in health and diseaseCombined Oral Contraceptive Pill Initiation in a Patient With Major Depressive Disorder, Premenstrual Dysphoric Disorder, Social Anxiety, Panic Disorder, and Histrionic Personality Disorder.Steroid withdrawal in the mouse results in anxiogenic effects of 3alpha,5beta-THP: a possible model of premenstrual dysphoric disorder.A new look at the 5alpha-reductase inhibitor finasteride.Prenatal Stress Alters Progestogens to Mediate Susceptibility to Sex-Typical, Stress-Sensitive Disorders, such as Drug Abuse: A Review.Effects and Mechanisms of 3α,5α,-THP on Emotion, Motivation, and Reward Functions Involving Pregnane Xenobiotic Receptor.Reversal of neurosteroid effects at alpha4beta2delta GABAA receptors triggers anxiety at pubertyProgesterone attenuates depressive behavior of younger and older adult C57/BL6, wildtype, and progesterone receptor knockout mice.Progesterone turnover to its 5α-reduced metabolites in the ventral tegmental area of the midbrain is essential for initiating social and affective behavior and progesterone metabolism in female rats.3alpha-hydroxy-5alpha-pregnan-20-one in the midbrain ventral tegmental area mediates social, sexual, and affective behaviorsThe neurobiology of postpartum depression.Progesterone reduces depressive behavior of young ovariectomized, aged progestin receptor knockout, and aged wild type mice in the tail suspension test.Trilostane exerts antidepressive effects among wild-type, but not estrogen receptor [beta] knockout mice.α4βδ GABAA receptors and tonic inhibitory current during adolescence: effects on mood and synaptic plasticityPuberty, steroids and GABA(A) receptor plasticity.Novel receptor targets for production and action of allopregnanolone in the central nervous system: a focus on pregnane xenobiotic receptorSystematic review of gamma-aminobutyric-acid inhibitory deficits across the reproductive life cycle.Stress and Premenstrual Symptoms in Reproductive-Aged Women.Reproductive Steroid Regulation of Mood and Behavior.[Ketoconazole antagonizes the immune and gonadotropic systems in the forced swimming test in male Wistar rats].Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstrual syndrome.Progesterone selectively increases amygdala reactivity in women.Neurosteroids for a successful pregnancy.Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome.In the ventral tegmental area, the membrane-mediated actions of progestins for lordosis of hormone-primed hamsters involve phospholipase C and protein kinase C.
P2860
Q24561815-2D909EC6-ADAA-480A-BFF8-92049358D8D3Q24618586-BFFB2C0A-5F92-4F5A-B9BB-B4CA4EC3C7B5Q24646222-E57B8CFC-2538-43E0-A2A0-A8A3D9E78D34Q26866177-BB877A51-B993-40F6-9898-CCF776FBBA61Q30430187-C09C4771-A83F-40E8-82AC-9F81002315CCQ30490678-059582D2-2A9C-49D1-BDF2-53C46416C5BEQ33792908-92658C28-BE85-4190-A196-39AD2D4A1D8DQ33802656-618DB3E4-6B54-488F-AB84-D30C6CBE5779Q33919767-BBA65183-6BDF-4E6A-AA3F-E804B1AB4699Q34546591-92EB2EC5-9490-4437-BD97-FA9DD214D2A2Q35367349-C35122F2-22DE-43E0-8F87-A14B46547141Q35681226-09AE9CF4-8C26-4646-893C-00555C5B5A9CQ35765765-8C0091ED-CEA0-4A45-9C44-E2B603BC17FBQ36036726-414045F3-A5A9-4E9E-BBAA-40A9462C8F6FQ36037910-A4E7B371-5B99-4D4D-8987-A2D9A1EEC351Q36329411-68E5121A-E176-43A5-A044-07AC37FA401EQ36363606-79B088FA-911B-4D4F-A4C4-518106B398ABQ36716452-D0E49910-732A-49FF-8B77-9147F0F2EC28Q36759118-E19B0F45-587E-424D-ADC6-3FBB65273B12Q37138725-59FD92DB-F04D-43C3-8ACE-A032959E65D8Q37479936-6726BD2E-E855-4813-88C7-3A16428D6C2EQ37705438-41E34C2A-F24B-42E0-8670-1082E583F031Q38178158-E1C4B14D-A9E9-4F80-9EDB-FAAC91EDE0BBQ38490842-A4AA4D35-CFEE-4D39-9729-D371A9DA7EB1Q38878217-8FFCDCEA-1CB0-4817-85E0-92842E28700CQ42961719-F76ADBC7-71A9-4231-B240-98B05228DE77Q44935076-A142460E-F0E8-4055-B004-E2D3E28123DCQ48131565-DF060302-1080-4291-9F55-C50175F8676BQ48304162-FF478E5D-0E8D-453A-9EEF-E5911951530AQ48591929-8B05CD24-73A6-48BB-8E34-9D211F50673BQ51795541-32995CE8-4824-4DB6-8E48-7DDD18DEAFAB
P2860
Allopregnanolone levels and symptom improvement in severe premenstrual syndrome.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Allopregnanolone levels and symptom improvement in severe premenstrual syndrome.
@en
Allopregnanolone levels and symptom improvement in severe premenstrual syndrome.
@nl
type
label
Allopregnanolone levels and symptom improvement in severe premenstrual syndrome.
@en
Allopregnanolone levels and symptom improvement in severe premenstrual syndrome.
@nl
prefLabel
Allopregnanolone levels and symptom improvement in severe premenstrual syndrome.
@en
Allopregnanolone levels and symptom improvement in severe premenstrual syndrome.
@nl
P2093
P1476
Allopregnanolone levels and symptom improvement in severe premenstrual syndrome.
@en
P2093
Cheryl A Frye
Ellen W Freeman
Karl Rickels
Paula A G Martin
P304
P356
10.1097/00004714-200210000-00013
P407
P577
2002-10-01T00:00:00Z